ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PRADYUMNA PADIVAL M.D.,F.A.C.C.

Cardiovascular Disease

22,797

$1.07M

975
836 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $65

RAMANA MURTY MD

Cardiovascular Disease

20,795

$1.01M

1059
867 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $65

SALIM DAHDAH M.D.

Cardiovascular Disease

18,323

$2.45M

1255
939 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 22%

$134
Average prescription price

Avg: $65

ADEL SHAHEEN MD

Cardiovascular Disease

17,933

$872K

1115
971 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $65

FADHIL HUSSEIN MD

Cardiovascular Disease

16,601

$928K

1046
932 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $65

FRANKLIN HANDEL M.D.

Cardiovascular Disease

15,623

$1.13M

1085
1012 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $65

NYAN WIN MD

Cardiovascular Disease

13,886

$840K

643
549 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $65

TARLOK PUREWAL M D

Cardiovascular Disease

13,210

$817K

457
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $65

RAFAEL SCHMULEVICH MD

Cardiovascular Disease

12,668

$657K

1064
962 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $65

DUANE POOL MD

Cardiovascular Disease

12,402

$644K

925
803 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $65

DEAN KEREIAKES M.D.

Cardiovascular Disease

12,310

$1.08M

929
861 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 22%

$88
Average prescription price

Avg: $65

GEORGE SEESE D.O.

Cardiovascular Disease

11,303

$452K

885
775 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $65

JAYATI RAKHIT MD

Cardiovascular Disease

10,657

$677K

460
348 are 65+

13%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $65

ASHIS RAKHIT MD

Cardiovascular Disease

10,595

$526K

470
331 are 65+

22%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $65

MILTON NATHAN MD

Cardiovascular Disease

10,460

$567K

936
867 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $65

AZMAT HUSSAIN MD

Cardiovascular Disease

10,263

$565K

536
446 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $65

AMJAD IQBAL M.D.

Cardiovascular Disease

10,137

$486K

794
672 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $65

PAUL BERLACHER MD

Cardiovascular Disease

10,087

$714K

1760
1572 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$71
Average prescription price

Avg: $65

DEVENDER BATRA MD

Cardiovascular Disease

10,057

$216K

932
739 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 22%

$22
Average prescription price

Avg: $65

MANMOHAN KATAPADI MD.F.A.C.C.

Cardiovascular Disease

9,878

$751K

840
575 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $65

AMEER KABOUR MD

Cardiovascular Disease

9,874

$497K

906
768 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $65

KEITH BRANTLEY MD

Cardiovascular Disease

9,791

$390K

730
636 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $65

RAKESH GUPTA MD

Cardiovascular Disease

9,777

$367K

605
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $65

PAUL ANIKE DO

Cardiovascular Disease

9,483

$546K

798
664 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $65

C JOFFE MD

Cardiovascular Disease

9,420

$1.92M

551
512 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 22%

$204
Average prescription price

Avg: $65

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank